Fat metabolism is associated with telomere length in six population-based studies.


Journal

Human molecular genetics
ISSN: 1460-2083
Titre abrégé: Hum Mol Genet
Pays: England
ID NLM: 9208958

Informations de publication

Date de publication:
31 03 2022
Historique:
received: 09 03 2021
revised: 13 08 2021
accepted: 07 09 2021
pubmed: 8 12 2021
medline: 9 4 2022
entrez: 7 12 2021
Statut: ppublish

Résumé

Telomeres are repetitive DNA sequences located at the end of chromosomes, which are associated to biological aging, cardiovascular disease, cancer and mortality. Lipid and fatty acid metabolism have been associated with telomere shortening. We have conducted an in-depth study investigating the association of metabolic biomarkers with telomere length (LTL). We performed an association analysis of 226 metabolic biomarkers with LTL using data from 11 775 individuals from six independent population-based cohorts (BBMRI-NL consortium). Metabolic biomarkers include lipoprotein lipids and subclasses, fatty acids, amino acids, glycolysis measures and ketone bodies. LTL was measured by quantitative polymerase chain reaction or FlowFISH. Linear regression analysis was performed adjusting for age, sex, lipid-lowering medication and cohort-specific covariates (model 1) and additionally for body mass index (BMI) and smoking (model 2), followed by inverse variance-weighted meta-analyses (significance threshold Pmeta = 6.5 × 10-4). We identified four metabolic biomarkers positively associated with LTL, including two cholesterol to lipid ratios in small VLDL (S-VLDL-C % and S-VLDL-CE %) and two omega-6 fatty acid ratios (FAw6/FA and LA/FA). After additionally adjusting for BMI and smoking, these metabolic biomarkers remained associated with LTL with similar effect estimates. In addition, cholesterol esters in very small VLDL (XS-VLDL-CE) became significantly associated with LTL (P = 3.6 × 10-4). We replicated the association of FAw6/FA with LTL in an independent dataset of 7845 individuals (P = 1.9 × 10-4). To conclude, we identified multiple metabolic biomarkers involved in lipid and fatty acid metabolism that may be involved in LTL biology. Longitudinal studies are needed to exclude reversed causation.

Identifiants

pubmed: 34875050
pii: 6409526
doi: 10.1093/hmg/ddab281
doi:

Substances chimiques

Biomarkers 0
Fatty Acids 0
Lipids 0

Types de publication

Journal Article Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

1159-1170

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Auteurs

Ashley van der Spek (A)

Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
SkylineDx B.V., Rotterdam, The Netherlands.

Hata Karamujić-Čomić (H)

Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

René Pool (R)

Department of Biological Psychology, Vrije Universiteit University Amsterdam, Amsterdam, The Netherlands.
Amsterdam Public Health Research Institute, Amsterdam University Medical Centers, The Netherlands.

Mariska Bot (M)

Department of Psychiatry and GGZ in Geest, Amsterdam Public Health Research Institute and Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands.

Marian Beekman (M)

Molecular Epidemiology, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.

Sanzhima Garmaeva (S)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Pascal P Arp (PP)

Department of Internal Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Sandra Henkelman (S)

European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Jun Liu (J)

Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Alexessander Couto Alves (AC)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
School of Biosciences and Medicine, University of Surrey, Guildford, UK.

Gonneke Willemsen (G)

Department of Biological Psychology, Vrije Universiteit University Amsterdam, Amsterdam, The Netherlands.
Amsterdam Public Health Research Institute, Amsterdam University Medical Centers, The Netherlands.

Gerard van Grootheest (G)

Department of Psychiatry and GGZ in Geest, Amsterdam Public Health Research Institute and Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands.

Geraldine Aubert (G)

Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, V5Z 1L3 British Columbia, Canada.

M Arfan Ikram (MA)

Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Marjo-Riitta Jarvelin (MR)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Center for Life Course Epidemiology, Faculty of Medicine, University of Oulu, Oulu, Finland.
Biocenter Oulu, University of Oulu, Oulu, Finland.
Unit of Primary Care, Oulu University Hospital, Oulu, Finland.

Peter Lansdorp (P)

Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, V5Z 1L3 British Columbia, Canada.
Departments of Medical Genetics and Hematology, University of British Columbia, Vancouver, V6T 1Z4 British Columbia, Canada.

André G Uitterlinden (AG)

Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Department of Internal Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Alexandra Zhernakova (A)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

P Eline Slagboom (PE)

Molecular Epidemiology, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.

Brenda W J H Penninx (BWJH)

Department of Psychiatry and GGZ in Geest, Amsterdam Public Health Research Institute and Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands.

Dorret I Boomsma (DI)

Department of Biological Psychology, Vrije Universiteit University Amsterdam, Amsterdam, The Netherlands.
Amsterdam Public Health Research Institute, Amsterdam University Medical Centers, The Netherlands.

Najaf Amin (N)

Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Cornelia M van Duijn (CM)

Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH